Martin B. Leon
Columbia University Medical Center
Center for Interventional Vascular Therapy
173 Fort Washington Avenue
Heart Center
USA
Name/email consistency: high
- Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Leon, M.B., Piazza, N., Nikolsky, E., Blackstone, E.H., Cutlip, D.E., Kappetein, A.P., Krucoff, M.W., Mack, M., Mehran, R., Miller, C., Morel, M.A., Petersen, J., Popma, J.J., Takkenberg, J.J., Vahanian, A., van Es, G.A., Vranckx, P., Webb, J.G., Windecker, S., Serruys, P.W. Eur. Heart J. (2011)
- Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Leon, M.B., Piazza, N., Nikolsky, E., Blackstone, E.H., Cutlip, D.E., Kappetein, A.P., Krucoff, M.W., Mack, M., Mehran, R., Miller, C., Morel, M.A., Petersen, J., Popma, J.J., Takkenberg, J.J., Vahanian, A., van Es, G.A., Vranckx, P., Webb, J.G., Windecker, S., Serruys, P.W. J. Am. Coll. Cardiol. (2011)
- Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) trial. Leon, M.B., Nikolsky, E., Cutlip, D.E., Mauri, L., Liberman, H., Wilson, H., Patterson, J., Moses, J., Kandzari, D.E. JACC. Cardiovasc. Interv (2010)
- A randomized comparison of the ENDEAVOR zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial. Leon, M.B., Mauri, L., Popma, J.J., Cutlip, D.E., Nikolsky, E., O'Shaughnessy, C., Overlie, P.A., McLaurin, B.T., Solomon, S.L., Douglas, J.S., Ball, M.W., Caputo, R.P., Jain, A., Tolleson, T.R., Reen, B.M., Kirtane, A.J., Fitzgerald, P.J., Thompson, K., Kandzari, D.E. J. Am. Coll. Cardiol. (2010)
- Late safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent compared with a paclitaxel-eluting stent in patients with de novo coronary lesions: 2-year follow-up from the ENDEAVOR IV trial (Randomized, Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). Leon, M.B., Kandzari, D.E., Eisenstein, E.L., Anstrom, K.J., Mauri, L., Cutlip, D.E., Nikolsky, E., O'Shaughnessy, C., Overlie, P.A., Kirtane, A.J., McLaurin, B.T., Solomon, S.L., Douglas, J.S., Popma, J.J. JACC. Cardiovasc. Interv (2009)
- Late clinical events after drug-eluting stents: the interplay between stent-related and natural history-driven events. Leon, M.B., Allocco, D.J., Dawkins, K.D., Baim, D.S. JACC. Cardiovasc. Interv (2009)
- Transcatheter aortic valve replacement in patients with critical aortic stenosis: rationale, device descriptions, early clinical experiences, and perspectives. Leon, M.B., Kodali, S., Williams, M., Oz, M., Smith, C., Stewart, A., Schwartz, A., Collins, M., Moses, J.W. Semin. Thorac. Cardiovasc. Surg. (2006)
- A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease. Leon, M.B., Kornowski, R., Downey, W.E., Weisz, G., Baim, D.S., Bonow, R.O., Hendel, R.C., Cohen, D.J., Gervino, E., Laham, R., Lembo, N.J., Moses, J.W., Kuntz, R.E. J. Am. Coll. Cardiol. (2005)
- Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. Leon, M.B., Teirstein, P.S., Moses, J.W., Tripuraneni, P., Lansky, A.J., Jani, S., Wong, S.C., Fish, D., Ellis, S., Holmes, D.R., Kerieakes, D., Kuntz, R.E. N. Engl. J. Med. (2001)
